Yi, Yan
Chai, Xiaoshan
Zheng, Liping
Zhang, Yongjing
Shen, Jiankai
Hu, Biliang
Tao, Guangshi
Article History
Received: 25 July 2020
Accepted: 25 February 2021
First Online: 27 April 2021
Conflict of interest
: All IP rights surrounding the technology in designing and engineering the CART cells used in this study belong to celledit and Siweikang Therapeutics. Biliang Hu is the founder of Celledit and Siweikang Therapeutics. All other authors declare no competing interests.